Seeking Alpha

  Vanda Pharmaceuticals Inc. - NASDAQ

11/28/2014, 2:04 AM ET
  • Justin M. Hall | Send Message 22 Dec 2010

    (VNDA) Hit $10 target on 12/21/10, and position was closed. Gain +52% from 7/8/10 Strong Buy recommendation =>
      VNDA vs. ETF Alternatives
      Company Description
      Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States